Showing results (2111-2120 of 3,340) with videos related to
Sort By:
Pageof 334
Metabolic Brain Disease|July 24, 2014
Acute hyperammonaemia induces a sustained decrease in vigilance, which is modulated by caffeineE P Casula, P S Bisiacchi, M Corrias, et al.Metabolic Brain Disease|July 27, 2014
Tumor necrosis factor beta NcoI polymorphism (rs909253) is associated with inflammatory and metabolic markers in acute ischemic strokeJohnathan de Sousa Parreira, Ana Paula Kallaur, Marcio Francisco Lehmann, et al.Metabolic Brain Disease|December 3, 2013
O-GlcNAcylation as a novel ammonia-induced posttranslational protein modification in cultured rat astrocytesAyşe Karababa, Boris Görg, Freimut Schliess, et al.Metabolic Brain Disease|December 6, 2013
Rats with minimal hepatic encephalopathy due to portacaval shunt show differential increase of translocator protein (18 kDa) binding in different brain areas, which is not affected by chronic MAP-kinase p38 inhibitionAna Agusti, Jennifer L Dziedzic, Vicente Hernandez-Rabaza, et al.Metabolic Brain Disease|April 23, 2013
Association of serum bilirubin and uric acid levels changes during neuroinflammation in patients with initial and relapsed demyelination attacksSrdjan Ljubisavljevic, Ivana Stojanovic, Slobodan Vojinovic, et al.Metabolic Brain Disease|March 16, 2013
Correlation between degree and quality of sleep disturbance and the level of neuropsychiatric impairment in patients with liver cirrhosisJayanta Samanta, Radha K Dhiman, Amit Khatri, et al.Metabolic Brain Disease|May 4, 2013
IL-10-producing B-cells limit CNS inflammation and infarct volume in experimental strokeSheetal Bodhankar, Yingxin Chen, Arthur A Vandenbark, et al.Metabolic Brain Disease|May 7, 2013
Association between the characteristics of metabolic syndrome and Alzheimer's diseaseHui-Ting Yang, Yi-Jing Sheen, Chuen-Der Kao, et al.Metabolic Brain Disease|April 2, 2013
Targeting oncogenic ALK and MET: a promising therapeutic strategy for glioblastomaGerald C Wallace, Yaenette N Dixon-Mah, W Alex Vandergrift, et al.Metabolic Brain Disease|April 16, 2013
Ferulic acid increases pain threshold and ameliorates depression-like behaviors in reserpine-treated mice: behavioral and neurobiological analysesYing Xu, Lu Zhang, Tuo Shao, et al.Pageof 334